Summary
Bristol-Myers Squibb Company (BMY) filed an 8-K on October 23, 2013, primarily to report its financial results for the third quarter of 2013. The filing includes a press release announcing these results and supplemental information available on the company's website. Investors should refer to the furnished press release (Exhibit 99.1) for the detailed financial performance and operational updates for the third quarter ending October 22, 2013. While the 8-K itself does not contain the specific financial figures, it directs stakeholders to the key documents where these details are disclosed. The supplemental information (Exhibit 99.2) may offer further insights into the company's performance, strategic initiatives, or market outlook. Investors are encouraged to review these exhibits to understand the company's financial condition and results of operations during the reporting period.
Key Highlights
- 1BMY announced its third quarter 2013 financial results on October 23, 2013.
- 2The announcement was made via a press release furnished as Exhibit 99.1 to the 8-K filing.
- 3Supplemental financial information is also available on BMY's website and furnished as Exhibit 99.2.
- 4This 8-K filing serves as the official notification of the Q3 2013 earnings release.
- 5Investors should consult the provided exhibits for detailed financial performance and operational results.